Textbook outcome in oncological gastric surgery: a systematic review and call for an international consensus

Table 2 Parameters included inTO

Author/year journal	Postoperative complication Clavien-Dindo	Length of stay	Mortality	Readmission	Lymph nodes examined > 15	Negative margins (R0)	Complete resection	Intraoperative complication	No reintervention	No readmission in ICU
Busweiler Br J Surg [1]	Yes CD ≥ II	Yes ≤ 21 days	Yes ≤ 30 days	Yes ≤ 30 days	Yes ≥ 15	Yes	Yes	Yes	Yes	Yes
Priego J Laparoend Adv Surg Tech [8]	Yes CD ≥ II	Yes ≤ 21 days	Yes ≤ 30 days	Yes	Yes > 15	Yes	Yes	No	Yes	Yes
van der Kaaij Br J Surg [4]	Yes CD ≥ II	Yes ≤ 21 days	Yes ≤ 30 days	Yes ≤ 30 days	Yes ≥ 15	Yes	Yes	Yes	Yes ≤ 30 days	Yes ≤ 30 days
Van der Werf Ann Surg [9]	Yes	Yes > 21 days	Yes	Yes	Yes ≥ 15	Yes	Yes	Yes	Yes	Yes
Carbonell-Morote Cir Esp [3]	Yes CD > IIIa	Yes < 21 days	Yes ≤ 30 days	Yes ≤ 30 days	Yes > 15	Yes	Yes	No	No	No
Dal Cero Eur J Surg Oncol [10]	Yes CD ≥ II	Yes ≤ 14 days	Yes ≤ 90 days	Yes ≤ 30 days	Yes ≥ 15	Yes	Yes	No	Yes ≤ 30 days	No
Sedłak Eur J Surg Oncol [11]	Yes DC ≥ II CCI ≥ 30	Yes ≤ 21 days	Yes ≤ 30 days	Yes	Yes ≥ 15	Yes	Yes	Yes	Yes ≤ 30 days	Yes
Bolger Eur J Surg Oncol [12]	Yes CD > II	Yes < 21 days	Yes ≤ 90 days	Yes ≤ 90 days	Yes ≥ 15	Yes	Yes	Yes	Yes	Yes
Levy Ann Surg [14]	NO severe complications	Yes	Yes	Yes	Yes ≥ 15	Yes	No	Yes	Yes	Yes
Roh Sci Rep Nature [13]	Yes CD ≥ II	Yes ≤ 21 days	Yes 30 days	Yes	Yes ≥ 15	Yes	No	Yes	Yes	Yes
Spolverato J Surg Oncol [7]	No	Yes	Yes	No	Yes ≥ 16	Yes	No	No	No	No
Cibulas Ann Surg Oncol [6]^a	No	Yes < 12 days	No	Yes ≤ 30 days	Yes ≥ 15	Yes	No	No	No	No

^aIncluded as TO parameter receipt of neoadjuvant and/or adjuvant chemotheraphy for pT3-T4 and/or pN1-N2 disease

ISSN: 1477-7819